Welcome to Penn PROMOTES

Penn PROMOTES Research on Sex and Gender in Health, founded by Dr. Neill Epperson and directed by Dr. Maria Oquendo and Dr. Courtney Schreiber, aims to illuminate our understanding of the wide-reaching and established sex differences in disease prevalence, phenomenology and treatment. Our Center employs a translational approach, integrating bench and clinical research, to understand these differences.

Penn PROMOTES serves as a virtual interdisciplinary center, housing disparate but fundamentally intertwined programs that include trainees, junior faculty and senior faculty. Penn PROMOTES encourages the incorporation of perspectives from different colleges within Penn, including the Perelman School of MedicineSchool of Veterinary MedicineSchool of Arts and Sciences and beyond. Penn PROMOTES evidences Penn's commitment to this division of health research and establishing Penn as an epicenter of innovative and inclusive research. 

Penn PROMOTES also serves as the fifth anchor program from the Perelman School of Medicine Office of Inclusion and Diversity. We join the ranks of four other key anchor programs within this Office.


  • New Mental Health Platform Provides Support for Healthcare Workers Thursday, May 28, 2020

    While mental health in the workplace is a longstanding and undertreated issue, it has been amplified as health professionals struggle with the extraordinary physical and emotional demands of COVID-19.

  • Gene Therapy Program at Penn Medicine Joins AAVCOVID Vaccine Project Thursday, May 28, 2020

    The internationally-renowned Gene Therapy Program at the University of Pennsylvania is joining the AAVCOVID vaccine program led by Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham for the joint research program.

  • Follow-up Treatments After Opioid Overdose Rare Among Insured Patients Wednesday, May 27, 2020

    The majority of commercially insured patients who visited the emergency department (ED) for an opioid overdose didn’t receive the timely follow-up care known to help prevent a future overdose or death, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania.